A summary of several of the many awards and honors received by Mays Cancer Center and its researchers during Fiscal Year 2022. 

Daruka Mahadevan, MD, PhD, division chief, hematology-oncology, director of the Institute of Drug Development and associate director for clinical research at Mays Cancer Center at UT Health San Antonio and his team have identified a series of small molecule compounds that target an enzyme, MAP4K3, important to amino acid signaling in autophagy, impacting neurologic diseases and cancer.

Jane Mattei, MD, joined Mays Cancer Center as a medical oncologist specializing in melanoma and other skin cancers and Gary Lewis, MD, has started as a radiation oncologist specializing in gynecologic brachytherapy and head and neck cancers.

We're thrilled to introduce four exceptional new doctors to our cancer center team! Their broad expertise and dedication make them ready to provide top-notch care and innovative treatments. Read to learn more about their impressive backgrounds and how they'll enhance our patient services.